Showing posts with label Public Health. Show all posts
Showing posts with label Public Health. Show all posts

Saturday, September 13, 2014

The Very Model Of A Modern Major General Public Health Disaster

image

The Epi Curve from Monrovia

 


# 9072

 

In two short weeks we’ve gone from viewing the World Health Organization’s warning that as many as 20,000 people in West Africa could be infected by the Ebola virus as being a worst case scenario, to that being among the more optimistic estimates. 

 

While no one knows for certain how bad things will become, partly because there isn’t a lot of confidence in our understanding of how bad things are now, the forecasts are becoming increasingly dire, with some estimates in the hundreds of thousands by year’s end.

 

George E. P. Box, Professor Emeritus of Statistics at the University of Wisconsin, famously declared that All models are wrong, but some models are useful.” , which helps to explain the huge diversity in estimatesAs does the computer programmers creed: GIGOgarbage in: garbage out.

Which means we probably shouldn’t latch too firmly to any of these estimates, but we should recognize the general (dismal) direction in which all of them are leaning.

 

Yesterday, Deutsche Welle carried a report - Ebola threatens to destroy Sierra Leone and Liberia – where German Virologist Jonas Schmidt-Chanasit  provides an even more apocalyptic forecast, saying the virus will likely become `endemic’ in those countries, and that most of their population could ultimately be infected.

 

Overnight the New York Times ran an article called Scientists present dire Ebola projection which carried this lede:

The deadly Ebola outbreak sweeping across three countries in West Africa is likely to last 12 to 18 months more, much longer than anticipated, and could infect hundreds of thousands of people before it is brought under control, say scientists mapping its spread for the federal government.

While there are mitigation efforts that could still blunt these projected impacts  and shorten this epidemic, for that to happen, it will require an unprecedented international effort, and some very good luck with the development of vaccines.  

And while the world tries to respond to this staggering Ebola outbreak, overburdened public health agencies around the globe will also be tasked with playing Whack-A-Mole against a variety disease threats with global aspirations – like Avian flu in Asia (H7N9, H10N8, H5N1), MERS-CoV in the Middle East, and of course the one we don’t know about yet . . . Virus X.


Given the the number and size of these threats, rather than cutting back on public health budgets, we really need be investing in a bigger mallet;  A global public health response team with the resources, and international backing, to investigate and coordinate a response to future emerging disease threats before they can spiral out of control.

 

Because the next threat that comes down the pike could make the carnage wrought by Ebola pale in comparison.


Wednesday, August 13, 2014

Gulf States Meet To Discuss Ebola Precautions For The Upcoming Hajj

image

Credit Wikipedia

 

# 8951

 

Even before MERS emerged in 2012, and the Ebola outbreak began to sweep across Guinea, Liberia and Sierra Leone this summer, preparing for the public health needs during the annual Hajj in Saudi Arabia was a big job. 

 

More than two million pilgrims – many of an advanced age and coming from regions of the world with relatively poor health care – make the journey each year and Saudi Arabia spends millions preparing to deal with their health issues.

 

The logistics of providing free medical care for several million pilgrims during the Hajj is a daunting one, and in  MERS, Mass Gatherings & Public Health, we looked at some of the immense  challenges that Saudi Arabia faces every year with the Hajj.

 

Emergence of medicine for mass gatherings: lessons from the Hajj

Prof Ziad A Memish MD , Gwen M Stephens MD, Prof Robert Steffen MD , Qanta A Ahmed MD

(Excerpt)

Within the immediate vicinity of the Hajj, there are 141 primary health-care centres and 24 hospitals with a total capacity of 4964 beds including 547 beds for critical care. The latest emergency management medical systems were installed in 136 health-care centres and staffed with 17 609 specialised personnel. More than 15 000 doctors and nurses provide services, all at no charge.

 

This confluence of millions of people into a confined space, coming from all over the world, provides a perfect `mixing bowl’  for viruses and bacteria, and has the real potential to seed them to new regions of the globe when the pilgrims leave. 

 

Last month, in EID Journal: Respiratory Viruses & Bacteria Among Pilgrims During The 2013 Hajj, we looked at the extraordinarily high percentage of Hajjis (approx. 80%)  who either acquire or leave with some type of respiratory infection while doing this pilgrimage. 

 

The vast majority of these respiratory infections were due to either rhinoviruses or influenza, with a smaller number of cases of pneumonia.


One of the concerns has been that it is pretty much impossible to differentiate between an early or mild MERS-CoV infection – and a more common viral illness like influenza -  without doing one (or more) lab tests. 

 

With the Hajj set for early October – a time of year when respiratory viruses are often on the rise, anyway – this will present some major public health challenges both in Saudi Arabia, and in those countries to where these travelers will return when the Hajj is over.

 

This year, added to the usual concerns, and the emerging threat of MERS, the Gulf States must also decide how best to protect against the Ebola virus.

 

While it was announced late last week that Saudi Arabia Bans Sierra Leone, Guinea, Liberia Muslims From performing HajjNigeria - which has reported 12 cases thus far -  remains a question mark. 

 

And there are concerns that other nations – particularly those bordering the affected countries – could potentially provide a conduit for the virus to make it to Saudi Arabia.

 

While we don’t have much in the way of details, today AFP is reporting:

 
Published: 13/08/2014 06:49 PM

Gulf states discuss Ebola precautions ahead of hajj

RIYADH - Representatives of the Gulf monarchies met in Riyadh on Wednesday to discuss precautions against the Ebola epidemic ahead of the annual hajj pilgrimage to Mecca in early October.

The executive bureau of the Gulf Cooperation Council's committee of health ministers met in the light of "preventive measures taken by some countries to protect against the Ebola virus... and the approach of the hajj," bureau director Taufik Khoja said. 

(Continue . . . )

 

Each year the challenges surrounding these mass gatherings seem to grow, as do the number of emerging infectious diseases they must deal with.  While the odds of Ebola showing up in Mecca during the Hajj this fall is probably small , it is a classic Low Risk – High Impact scenario, and must be planned for.

 

The good news is that despite concerns to the contrary – due to abundant good public health planning and perhaps a bit of luck – we’ve seen venues like last year’s Hajj, the FIFA World Cup in Brazil, the 2012 London Olympics, and the UEFA EURO 2012 football championship come off without any serious public health incidents (see How The ECDC Will Spend Your Summer Vacation).

 

The goal is making sure that that lucky streak remains intact.

 

For those contemplating making the Hajj this year, the CDC provides specific travel advice , including required and recommended vaccinations.

image

Monday, July 28, 2014

MERS: The Price Of Vigilance

image

 

# 8874

 

Although there’s been a precipitous drop in the number of MERS cases reported by Saudi Arabia (and other) Middle Eastern nations over the past month, concerns remain that international travelers could carry the virus to other areas of the globe. 

 

While not always making headlines, many countries are engaged in testing for the virus among symptomatic travelers coming from the Middle East.  

 

Today, we’ve a report from Hong Kong’s CHP on three people being tested (1 has intially tested negative).  Over the past year Hong Kong has tested scores of travelers for MERS, and thus far, all have proved negative. First the report, then I’ll return with more:

.

Three suspected cases of MERS

 
The Centre for Health Protection (CHP) of the Department of Health (DH) is today (July 28) investigating two suspected cases of Middle East Respiratory Syndrome (MERS) affecting a 34-year-old man and a 45-year-old woman, and called on the public to stay alert and maintain good personal, food and environmental hygiene during travel. In addition, the CHP provided an update on the suspected case of MERS notified yesterday (July 27). The 2-year-old boy's respiratory specimen tested negative for MERS Coronavirus (MERS-CoV).


The first patient is a 34-year-old man with good past health. He travelled from Pakistan to Hong Kong via Dubai yesterday and arrived in Hong Kong today. He has presented with fever and vomiting and was screened to have fever at the Hong Kong International Airport today. He was subsequently transferred to Princess Margaret Hospital for isolation. He is currently in stable condition.


The second patient is a 45-year-old woman with good past health. She returned to Hong Kong from Paris via Dubai on July 25 and arrived in Hong Kong on July 26. She has presented with fever and diarrhoea since yesterday and was admitted to Princess Margaret Hospital for isolation today. She is currently in stable condition.


Both patients' respiratory specimens have been collected for laboratory testing by the CHP's Public Health Laboratory Services Branch (PHLSB). Their travel collaterals have remained asymptomatic.


Regarding the suspected case of MERS notified yesterday, the 2-year-old boy's nasopharyngeal aspirate tested negative for MERS-CoV upon preliminary laboratory testing by the CHP's PHLSB. The patient travelled with his family from Dubai to Hong Kong on July 23. He has presented with fever since July 24 and cough since July 26. He was admitted to Princess Margaret Hospital on July 26 and has been in stable condition. His travel collaterals remain asymptomatic. 

"We strongly advise travel agents organising tours to the Middle East not to arrange camel rides and activities involving camel contact, which may increase the risk of infection. In addition, travellers are reminded to avoid going to farms, barns or markets with camels, and avoid contact with animals, especially camels, birds, poultry or sick people during travel," a spokesman for the DH said.

(Continue . . . .)

 

The odds are that these cases, like the ones before them, will test negative for the virus.  

 

But the truth is, as long as the virus continues to occasionally infect humans in the Middle East, public health officials in Hong Kong – and around the world – must be alert to the possibility that international travelers could be arriving with the virus.

 

A little over a week ago, in EID Journal: Respiratory Viruses & Bacteria Among Pilgrims During The 2013 Hajj, we looked at the extraordinarily high percentage of Hajjis (approx. 80%)  who leave Saudi Arabia with some type of respiratory infection.  The vast majority of these respiratory infections were due to either rhinoviruses or influenza, with a smaller number of cases of pneumonia.

 

While MERS wasn’t a major factor among religious pilgrims last year, since that time the number of MERS cases in Saudi Arabia has increased five-fold, and any traveler leaving the region who develops respiratory symptoms is urged to be screened for MERS-CoV.


Whether or not MERS infections surge during the Hajj, public health agencies around the world are going to be taxed by the sheer volume of symptomatic (with `something’) travelers returning from the Middle East this fall.   Most (hopefully, all) will have something mundane, like seasonal influenza or the common cold.

 

Hong Kong’s CHP is particularly pragmatic when it comes to the potential for seeing MERS arrive in their jurisdiction.  In their new release, they also advise:

 

Early identification of MERS-CoV is important, but not all cases can be detected in a timely manner, especially mild or atypical cases. Health-care workers (HCWs) should maintain vigilance and adhere to strict infection control measures while handling suspected or confirmed cases to reduce the risk of transmission to other patients, HCWs or visitors. Regular education should be provided.


Travellers returning from the Middle East who develop respiratory symptoms should wear face masks, seek medical attention and report their travel history to the doctor. HCWs should arrange MERS-CoV testing for them. Patients' lower respiratory tract specimens should be tested when possible and repeat testing should be undertaken when clinical and epidemiological clues strongly suggest MERS.

 

While having more MERS cases spreading internationally this fall would be a serious public health concern, just the threat of seeing the virus arrive poses a tremendous challenge for public health agencies around the world.

 

And this comes at a time when public health funding and staffing in the United States continues to erode (see TFAH report Investing in America’s Health: A State-by-state Look at Public Health Funding & Key Health Facts).

 

Even as funding for public health declines, the number of global disease threats only seems to be increasing. 

To MERS-CoV we can add H5N1, H7N9, Chikungunya, Dengue, Ebola, Lassa Fever,  CCHF, Polio, NDM-1, CRE, XDR-TB  . . .  and of course the one we don’t know about yet . . . Virus X.

 

Faced as we are with an ever expanding rogue’s gallery of pathological fliers, the recent cuts in public health spending are all the more difficult to fathom.  And are an economy we could easily come to regret.

Friday, May 23, 2014

Dealing With A Lighter Shade Of MERS

image

Photo Credit- CDC

 

# 8655

 

With the spring surge in MERS cases in the Middle East, and a (thus far) small number of exported cases to countries like Greece, Malaysia, The Netherlands, and the United States, we’ve seen a lot of talk (pro and con) on the pandemic potential of the emerging MERS coronavirus.  

 

It’s an understandable debate, as a pandemic would have a huge global impact - and if one were in the wings -now is the time we should be preparing for it.

 

Although we’ve seen some impressively large clusters in healthcare settings, so far, the illness hasn’t spawned large outbreaks in the community, and its spread outside of the Arabian peninsula has been anemic. So far, the consensus appears to be that the MERS coronavirus is not yet sufficiently transmissible enough to spark a pandemic.

 

Good news.  With the caveat being that viruses have a nasty habit of changing over time.

 

This disease’s future isn’t a binary one, however;  a `pandemic or nothing’ proposition.  Even in its present incarnation, it has the potential to be a long-term, high-impact problem.

 

Already, with just two introductions into the United States, we’ve seen its expensive and disruptive effects; hundreds of people potentially exposed, scores of healthcare workers furloughed to home isolation, extensive contact tracing & testing programs initiated, and scores of lives and jobs interrupted.


And while only impacting two healthcare facilities directly, the ripple effects – implementing better screening, testing, and heightened infection control in anticipation of future cases – extend to all medical facilities. 

 

The irony is, that as long as a pathogen has unrealized `pandemic potential’, public health attempts to contain it in some ways are more extensive and disruptive than efforts to deal with it after it becomes a pandemic.

 

The arduous process of contact tracing and testing of potentially exposed airline passengers makes sense as long as the virus remains rare, but quickly becomes moot once a virus become pervasive in the community. Similarly, the public health value of stringent isolation and quarantine policies diminish as a pandemic progresses.

 

While better than dealing with a pandemic, fighting a `cold war’ against an emerging infectious disease threat can be protracted, expensive, and exhausting proposition –  much like the battle that has been waged these past few years against emerging antibiotic resistant organisms like NDM-1 and CRE (see MMWR Vital Signs: Carbapenem-Resistant Enterobacteriaceae (CRE)).

 

The spread of HAIs (Hospital Acquired Infections) has cost us hundreds of thousands of lives and billions of dollars over the past decade, and despite elaborate measures taken to prevent them, the `bugs’ seem to be winning. 


Even with limited `droplet or airborne’ transmissibility, MERS-CoV adds to the complexity of infection control in medical settings, meaning that even a handful of imported cases each month have the potential to severely impact healthcare facilities, and many lives, across the nation.

 

It doesn’t require a Stephen King-styled pandemic to turn MERS into a major problem.  A small but steady influx of MERS cases could do that as well – particularly when stacked on top of the growing list of other emerging (although not necessarily pandemic) disease threats.

 

A partial list of ongoing or emerging global health threats we’ve discussed includes:

 

 

To this short list you can add the continual spread of H7N9 and H5N1 avian flu viruses (see The Expanding Array Of Novel Flu Strains) in Asia and the Middle East, Polio in the Middle East and Africa, contaminated food or drugs, XDR-TB, and of course the one(s) we don’t even know about yet . . Virus X.

 

All of which makes the recent cuts in public health spending all the more egregious, dangerous, and foolhardy.

 

A recent report  from TFAH (Trust for America’s Health) finds a steady decline in the resources available to public health across the nation. 

 

Investing in America’s Health: A State-by-state Look at Public Health Funding & Key Health Facts

image

 

May 2014

Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF) released Investing in America's Health: A State-by-State Look at Public Health Funding and Key Health Facts. This is the ninth time the report has been released.

In Investing, TFAH and RWJF examine public health funding and key health facts for each state, finding:

  • Wide Variation in Health Statistics by State:  There are major differences in disease rates and other health factors in states around the country.  For instance, only 7.0 percent of adults in Alaska have diabetes compared to 13.0 percent in West Virginia, and 28.3 percent of adults in Kentucky are current smokers while only 10.6 percent report smoking in Utah.
  • Cuts in State and Local Funding:  At the state and local levels, public health budgets have been cut at drastic rates in recent years.  According to a TFAH analysis, 33 states and Washington, D.C. decreased their public health budgets from FY 2011-12 to FY 2012-13.  Budgets in 20 states decreased for two or more years in a row, and budgets in 16 states decreased for three or more years in a row. 
  • In FY 2012-13, the median state funding for public health was $27.49 per person, ranging from a high of $144.99 in Hawaii to a low of $5.86 in Missouri.  From FY 2008 to FY 2013, the median per capita state spending decreased from $33.71 to $27.49.  This represents a cut of more than $1.3 billion (adjusted for inflation).
  • Flat Federal Funding:  Federal funding for public health has remained at a relatively flat level for years.  The budget for CDC has decreased from a high of $7.07 billion in 2005 to $5.98 billion in FY 2013 (adjusted for inflation). Spending through CDC averaged to only $18.92 per person in FY 2013.  And the amount of federal funding spent to prevent disease and improve health in communities ranged significantly from state to state, with a per capita low of $13.67 in Indiana to a high of $46.48 in Alaska. 

Overall, the report concludes that the nation must shore up core ongoing funds for public health. In addition, the report recommends ensuring the Prevention and Public Health Fund is used to build upon and expand— not supplant – existing efforts.

(Continue . . .)

 


Even as the number of global disease threats continue to rise, we seem blindly intent on gutting our only line of defense  – our state, local, and Federal public health systems.  In this climate of budget cutbacks, when combined with an ever growing list of other public health challenges, even dealing with a lighter shade of MERS may prove a serious challenge.

 

The old adage is true, `When public health works, nothing happens’

 

The one thing we really, really don’t want to ever see in this country is what would happen if public health no longer worked.   

Saturday, April 12, 2014

KSA: Public Health Messaging On MERS

 image

Credit KSA MOH

 

# 8464

 

In my last blog (see MERS-CoV: The Twitter Of Their Discontent) I wrote about some of the dubious medical advice being purveyed by Arabic newspapers and on Twitter for dealing with the MERS Coronavirus.  Luckily, more reasoned public health advice is being promoted as well.


An example comes from a widely tweeted link to the following SAAID.net story.

 

8 important questions of Corona

Dr. Mohammed Al-Filali
Doctor in public health and preventive medicine @mh_filali


Dr. Osama barshid
Doctor in public health and preventive medicine @DrOsamah1

In the name of God the merciful

With increasing cases of Corona recently spread messages about the disease and its treatment and other. To minimize rumors and disseminate correct information about the disease we have group of physicians to answer some important questions about the disease to raise awareness in society.


First: what are the symptoms of the disease?

Most of the cases these symptoms appeared


- High temperature.
- Cough (cough).
- Shortness of breath.
- Symptoms such as sneezing, nominated or cold and runny nose.

Secondly: what do I do if these symptoms?


- Visit the health center or family doctor.
- The antihypertensive and painkillers, according to the doctor's instructions.
- A lot of liquids.
- Take enough rest.
- Avoid mixing with other people, especially children, the elderly or those with chronic symptoms.


Third: when to go to emergency?

- If symptoms are intensified.
- Or if the victim's age or suffering from chronic diseases or have low immunity.
- Or if there is contact with a person infected or suspected of infection during the two weeks preceding the onset of symptoms.


IV: what is the treatment?

- Not discover the cure for this disease, which is treating the symptoms and provide nutrients and supportive therapies to reduce complications.


VA: what are the health message across about as garlic as a remedy?


- Nothing proves the effectiveness of garlic as a cure for this disease. If there is proof of the effectiveness of garlic as an antibiotic relative to a specific type of bacteria, the metastatic disease is a viral disease and viral infections are treated with antibiotics.
But we can say that garlic in General may benefit like other natural substances such as honey, black seed in lifting the immunity, but is by no means a cure for the disease.

VI: is a dangerous and deadly disease?

- From the beginning of the discovery of the disease two years ago in April 2012 and March 27, 2014 were 206 cases in the world occurred in 86 of them or rough (42%), most deaths were in the elderly and patients with chronic diseases.


- There may be fewer deaths if there are cases of Corona light did not require testing and treatment.

7. How do I protect myself and around me from disease?

1) there is not a vaccine (immunization) specific to the disease, but can take the seasonal flu vaccination to prevent God from other types of influenza a swine flu (H1N1) and others.


2) Avoid contact with beauty and away from places and should make sure the boiling wetvoir camel milk if drinking it, and cook meat well before eating. Because the studies suggesting a link between HIV and beauty as a vector of disease.


3) It is also advised to take preventive measures for any disease is contagious and I am are as follows:

- Wash hands with SOAP and water or sterilizers.
- Avoid touching eyes, nose and mouth before washing.
- Avoid shaking hands or sitting patients.
- Cover your mouth with a tissue when you cough or sneeze with direct disposal of the handkerchief.
- Wear masks when mixing in large concentrations.

4) Cooperation with the Ministry of health in case samples or information from persons or contacts them to study and learn more about its properties.

5) Immunization and adhkaar in this period and in a while.

8. do you avoid going to hospital?


- When you need to visit the doctor advised to visit health centers and go to the hospital emergency where critical situations only.


Finally we ask God for a speedy recovery for each patient, mercy and forgiveness of the dead and to protect us and loved ones and everyone from all evil.

References:
-American Center for prevention of diseases (CDC)
-World Health Organization (WHO)
-Ministry of health

 

 

With a growing number of mild and/or asymptomatic infections being reported among known contacts of infected persons, the obvious trade-off with telling people with `mild or moderate symptoms’  not to go to the hospital is that community cases of MERS infection may not be as easily detected, or infected patients isolated.

 

It is likely, of course, that some mild or asymptomatic cases have been missed all along. 

 

While not ideal --the alternative – having thousands of worried well, along with some mildly ill patients show up at ERs around the nation could easily overwhelm and disrupt emergency medical services.

 

Not only for those worried about their coronavirus status, but for every other medical emergency as well.

 

One can only hope that doctors and health clinics are being instructed to refer the vast majority of suspected cases for further testing.

Thursday, November 21, 2013

Locally Acquired Dengue In New York City

image

Credit Martin County Health Department

 

# 7996

 

 

With ever increasing international travel in recent years we’ve seen an increase in people arriving in, or returning to the United States who have been infected with dengue while visiting a country or region where the virus is endemic. While not contagious in the classical sense,those infected can pass on the virus to others if they donate blood, either intentionally, or via a mosquito proxy.

 

After an absence of 6 decades, Florida has reported sporadic locally acquired dengue cases over the past four year (see Florida: Dengue Forces Suspension Of Blood Donations In Two Counties). The virus is believed to have been introduced into the local mosquito population by infected (viremic) international visitors.

 

So far, the virus hasn’t managed to establish itself as a permanent fixture. But there are researchers who are seriously concerned that with a susceptible mosquito population and repeated introductions of the virus, that dengue could get a foothold in Florida, and many other areas of the nation.

 

In 2009 the Natural Resources Defense Council (NRDC) released a report outlining the risks that Dengue could re-establish itself in North America, that included this map showing the areas of the United States that are vulnerable to the introduction of Dengue.

image

Northern climes are far less likely to see dengue take hold than say, Florida or Southern Texas. Still, in the 18th and 19th century, both Malaria and Yellow Fever were endemic up and down the mid-Atlantic coast.

 

While not exactly a hotbed of tropical disease infections, we’ve a story out of Long Island, New York yesterday regarding a local resident – who had not traveled outside of the metropolitan area in recent months – who was hospitalized with dengue in September.  The 50-year-old man has since recovered (see CBS-TV2 news report New York State’s First Known Dengue Fever Infection Found On Long Island).

 

From the Suffolk County Health Department we get the following statement.

 

November 20, 2013

Health Commissioner Reports Dengue Virus Case

Suffolk County Commissioner of Health Services James Tomarken reported today that health officials have identified a case of dengue virus in a resident of Suffolk County. A male over 50 years of age from the Township of Babylon was hospitalized in September 2013 with symptoms consistent with dengue virus. He has since fully recovered.

 

Dengue virus is transmitted to humans by the bite of a mosquito. This case is significant in that it is known to be the first locally acquired case of dengue virus in New York State. While Suffolk County had two confirmed cases of dengue virus in 2012 and three in 2011, those individuals are thought to have acquired the virus while traveling in dengue endemic regions of the world.

 

It is estimated that there are over 100 million cases of dengue worldwide each year. Southern Florida, southern Texas, and Hawaii are the only areas in the United States where locally acquired dengue fever transmission has routinely occurred. In the Western Hemisphere, the Aedes aegypti mosquito is the most important transmitter or vector of dengue viruses, although the Aedes albopictus, known locally as the Asian Tiger mosquito, can transmit disease.

 

“The exact route of transmission in this case is unknown,” said Dr. James Tomarken, Suffolk County Commissioner of Health Services. “However, we have determined that this individual acquired dengue virus locally, as he had not traveled outside of the local metropolitan area during the incubation period.”

 

This individual was likely infected locally with dengue virus when bitten by a mosquito that had previously bitten an infected traveler. Both state and local health officials say that despite this isolated finding of locally acquired dengue virus in New York, they do not expect that dengue virus will become widespread in the region, as the temperate climate in New York does not lend itself to sustained transmission of the virus.

 

"Given the recent introduction of Aedes albopictus into New York State and the high level of travel in New York to areas of the world endemic for dengue, it is not surprising that a locally acquired case of dengue has been found in the state," said State Health Commissioner, Nirav R. Shah, M.D., M.P.H. "This finding emphasizes the need for physicians to be aware of signs and symptoms of diseases common in tropical countries, but may occasionally present themselves in New York.”

 

The principal symptoms of dengue fever are high fever, severe headache, severe pain behind the eyes, joint pain, muscle and bone pain, rash, and mild bleeding or bruising. The more severe form of the disease, Dengue Hemorrhagic Fever (DHF), can be fatal, and most commonly occurs when someone is infected with dengue for the second time. There is no immunization for dengue virus, and there is no specific treatment for a dengue infection. Individuals with symptoms are advised to consult their health care providers.

 

The best preventive measure for mosquito-borne diseases is to reduce mosquito breeding areas around homes, primarily artificial containers that hold water. Proper application of mosquito repellents containing DEET, decreases the risk of being bitten by mosquitoes.

 

Although New York State is not thought to have mosquito populations endemic with dengue, Suffolk County maintains a long-term community-based plan to reduce mosquito populations and prevent other mosquito-borne diseases that are endemic to the region, including West Nile virus.

 

One locally acquired case of dengue in New York City – while surprising - serves more as a cautionary note than as an alarm bell.

 

It’s a not-so-subtle reminder that the barriers we erect against infectious diseases – like mosquito control programs, vaccinations, and public health departments – are as vital as they are tenuous, and can fail us if we do not maintain and support them. 

 

Whether we are talking dengue or malaria, polio or measles, or diphtheria or yaws  - the threats we’ve eradicated from the United States today still exist elsewhere in the world - and without constant vigilance, could someday return.

 

The old saying is true, `When public health works, nothing happens’.

Sunday, June 23, 2013

BMC Public Health: H5N1 In Indonesia, Diagnosis, Treatment & CFR

image

 

# 7422

 

One of the enigmas surrounding the H5N1 virus is the wide disparity in fatality rates between countries. As you can see from the chart above, Indonesia’s CFR (Case Fatality Ratio) is more than twice that of Egypt.

 

Of the nations that have reported cases, Bangladesh has the best record, with only a 14% fatality rate.

 

Granted, these numbers are likely skewed by differences in surveillance, testing, and reporting around the world, but they are what we have to work with.

 

One of the unknowns is the relative health impact of different clades of the H5N1 virus (until recently, Indonesia had only dealt with clades 2.1.1, 2.1.2. and 2.1.3, but now adds 2.3.2. – while clades 2.2.1 and 2.2 are endemic in Egypt).

 

But other factors have been posited, including delays in seeking healthcare and, once sought, the speed and quality of diagnosis and treatment.

 

A study, recently published in BMC Public Health, looks at the treatment and outcome of 124 cases of H5N1 infection reported in Indonesia between 2005 and 2010, and finds serious delays in the time between seeking medical treatment and an accurate diagnosis and antiviral treatment for the virus.

 

Human influenza A H5N1 in Indonesia: health care service-associated delays in treatment initiation

Wiku Adisasmito, Dewi Nur Aisyah, Tjandra Yoga Aditama, Rita Kusriastuti, ¿ Trihono, Agus Suwandono, Ondri Dwi Sampurno, ¿ Prasenohadi, Nurshanty A Sapada, MJN Mamahit, Anna Swenson, Nancy A Dreyer and Richard Coker

BMC Public Health 2013, 13:571 doi:10.1186/1471-2458-13-571

Published: 11 June 2013

Abstract (provisional)
Background

Indonesia has had more recorded human cases of influenza A H5N1 than any other country, with one of the world's highest case fatality rates. Understanding barriers to treatment may help ensure life-saving influenza-specific treatment is provided early enough to meaningfully improve clinical outcomes.

Methods

Data for this observational study of humans infected with influenza A H5N1 were obtained primarily from Ministry of Health, Provincial and District Health Office clinical records. Data included time from symptom onset to presentation for medical care, source of medical care provided, influenza virology, time to initiation of influenza-specific treatment with antiviral drugs, and survival.

Results

Data on 124 human cases of virologically confirmed avian influenza were collected between September 2005 and December 2010, representing 73% of all reported Indonesia cases. The median time from health service presentation to antiviral drug initiation was 7.0 days. Time to viral testing was highly correlated with starting antiviral treatment (p < 0.0001). We found substantial variability in the time to viral testing (p = 0.04) by type of medical care provider. Antivirals were started promptly after diagnosis (median 0 days).

Conclusions

Delays in the delivery of appropriate care to human cases of avian influenza H5N1 in Indonesia appear related to delays in diagnosis rather than presentation to health care settings. Either cases are not suspected of being H5N1 cases until nearly one week after presenting for medical care, or viral testing and/or antiviral treatment is not available where patients are presenting for care. Health system delays have increased since 2007.

The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.

 

 

The therapeutic effects of antivirals, like oseltamivir, are the most pronounced in the first 48 hours of infection. After that, some benefit may be derived, but its effects are greatly diminished.

 

In Indonesia, this study found the average time between seeking medical treatment, and receipt of antivirals, was 7 days.  Too late to have much effect.

 

The authors write in the discussion section:

 

A low clinical suspicion of disease by health care workers likely remains an important impediment to early diagnosis, virological confirmation, and appropriate treatment initiation [13].

 

The signs and symptoms during the first two days of disease in cases reported here were mostly non-specific. This nonspecific clinical presentation of influenza A (H5N1) disease raises challenges.

 

The differential diagnosis of cases may include other influenza-like illnesses, dengue, or typhoid [14], to the exclusion of influenza A (H5N1). In an earlier report, only 12% of influenza H5N1 cases were initially diagnosed as having influenza H5N1
[13].

 

There’s a good deal of data included in this report, including demographic information on cases, CFRs based on the type of medical facility where patients were first seen, and a detailed list - by patient symptoms – of the time to seeking medical care, time to testing, and time to antiviral treatment. 

 

The authors conclude by writing:

 

Conclusions


Reducing health care system delays in the initiation of specific treatment for patients infected with influenza H5N1 is no easy matter. The non-specific nature of  the disease, especially in the early days, suggests a number of options that might be considered.

 

The application of rapid diagnostic tests on presentation to confirm or refute the diagnosis might enable clinicians to tailor their treatment better. Alternatively, the initiation of treatment when clinical suspicion is raised might offer benefits to the minority who actually have influenza H5N1.

 

Both of these approaches have cost implications that need to be determined. Prospective clinical studies too may offer more robust data on clinical symptoms and signs associated with differentiating H5N1 from other diseases as well as determining those likely to fare least well clinically and thus benefit most from influenza specific clinical interventions.

Sunday, February 24, 2013

SARS And Remembrance

 

image

Credit World Health Organization – May 2003

 

# 6964

 

 

This third week of February, the 21st day to be exact, is the 10th anniversary of the arrival of SARS (Severe Acute Respiratory Syndrome) to Hong Kong. While the virus had been percolating stealthily across rural China since the previous November, this was its first known border crossing.

 

The virus arrived via a 64-year-old Chinese physician from neighboring Guangdong Province who had recently treated atypical pneumonia cases at Zhongshan hospital.

 

Asymptomatic when he began his journey, by the time he checked into a 9th floor room of the Metropole Hotel, he was beginning to show signs of illness. Exactly how the virus was transmitted to a dozen guests or more staying at that four-star hotel may never be known.

 

Perhaps he coughed while standing in a crowded elevator, or contaminated door handles or the pen at the register when he signed in at the lobby. It was speculated he might have even vomited in the hallway.

 

In October of 2003, WHO issued a consensus document on the epidemiology of SARS that included:

 

– The implications of the Metropole Hotel outbreak are not yet fully understood.


Intensive investigations of circumstances surrounding the late-February outbreak in the Metropole Hotel, Hong Kong, which seeded the international spread of SARS, have not yet answered all questions. During this incident, the virus was transmitted to at least 16 guests and visitors, all linked to the 9th floor of the hotel. The results of environmental sampling on the carpet outside room 911, where the index case resided, and elevator areas show a hot zone (possibly vomitus or respiratory secretions). Samples were PCR positive for the virus 3 months after the index case spent a single night at the hotel. Although tests demonstrated the presence of SARS coronavirus RNA and not viable virus, this finding may have implications for the persistence of the virus in the environment.

 

The Metropole Hotel outbreak is recognized as a “superspreading event”. However, the index case did not have an unusually high viral load when tested on days 9 and 11 of illness.

 

By whatever means, Dr. Liu Jianlun – who died in a Hong Kong hospital two days later – became known as as the first international `super spreader’ of the disease.


The results of his fateful visit to Hong Kong are recounted below in the WHO document Severe acute respiratory syndrome (SARS): Status of the outbreak and lessons for the immediate future.

 

Days later, guests and visitors to the hotel’s ninth floor had seeded outbreaks of cases in the hospital systems of Hong Kong, Viet Nam, and Singapore.

 

Simultaneously, the disease began spreading around the world along international air travel routes as guests at the hotel flew home to Toronto and elsewhere, and as other medical doctors who had treated the earliest cases in Viet Nam and Singapore travelled internationally for medical or other reasons.

 


This still unidentified virus quickly began to show up in Vietnam, Singapore, and even Toronto – and hospital workers – unaware that a new, virulent and highly infectious pneumonia virus was before them, were exposed and infected.

 

By March 12th, after reviewing the situation in Hanoi, Hong Kong, and Beijing, WHO issues a global alert about cases of atypical pneumonia warning that Cases Of Severe Respiratory Illness May Spread To Hospital Staff.

 

Two days later (March 14th), three cases appeared in Singapore, brought in most likely by a flight attendant who had also stayed at the Metropole hotel in Hong Kong. 

 

The next day, the World Health Organization issues emergency travel advisory as it became apparent that whatever this virus was, it was spreading rapidly.

 

This syndrome, SARS, is now a worldwide health threat,” said Dr. Gro Harlem Brundtland, Director General of the World Health Organization. “The world needs to work together to find its cause, cure the sick, and stop its spread.”

 

While the virus was definitely on the move, eventually making it to more than 30 countries, no city was harder hit than was Hong Kong.

 

Between March 11th and June 6th, a total of 1750 cases were identified, and of those, 286 died.

 

In time, the virus was identified, and contained (see Hong Kong’s Coronavirus Response), with quarantine being the most effective weapon in the public health department’s arsenal. 

 

But not before nearly 8,000 were infected worldwide, and nearly 800 died.

 

Bad . . . but not as bad as it might have been.  In many ways we were lucky that time. 

 

Unlike with influenza, patients were not infectious until they displayed overt symptoms, making the identification and isolation of cases possible.

   

Last month, In EID Journal: A Brief History Of Quarantine, we looked at the long, successful history of this most basic of public health interventions, and how it was utilized during the SARS outbreak. I wrote:

 

During the 2003 SARS epidemic, Isolation was used in the United States for patients who were ill, but since transmission of the virus was very limited here, quarantine was not recommended for those exposed (cite).

 

In other countries, where transmission risks were greater, quarantines were used – quite successfully – in order to contain the virus. 

  • Singapore was one of the first countries to mandate quarantines when more than 800 family members of SARS patients were ordered to stay in their homes. 
  • Hong Kong sealed part of the Amoy Gardens Apartment complex after scores of cases erupted there, and later moved all remaining residents to two holiday camps where they were quarantined.
  • And Toronto, Canada closed schools and quarantined thousands in their bid to contain the virus (see The SARS Experience In Ontario, Canada).

The graph below shows two distinct phases of disease transmission in Canada, both apparently dampened by the implementation of quarantines.

image

While the aggressiveness of quarantine measures taken in Toronto have been criticized by some (see Severe acute respiratory syndrome: Did quarantine help?), many experts have stated that quarantining those exposed (usually in their own homes) helped to halt the epidemic.

 

The full story of the SARS outbreak is both long, and fascinating, and I heartily recommend both Karl Taro Greenfeld’s  The China Syndrome: The True Story of the 21st Century's First Great Epidemic and David Quammen’s excellent book  Spillover: Animal Infections and the Next Human Pandemic.

 

The remembrance of this crisis has no doubt helped to amplify the concerns of the public - and health officials - in Asia, and around the world over the recent emergence of another coronavirus in the Middle East.


 

This novel coronavirus (NCoV) is not SARS, and so far it has failed to demonstrate an ability to spread as easily as did SARS.

Nevertheless, this week - along with a lot of media stories recalling the the 2003 SARS epidemic, we are seeing a number of cautionary statements from doctors and researchers regarding this NCoV.

 

Vigilance urged over new coronavirus 

 

Concerted efforts in enhancing surveillance and control measures for novel coronavirus

 

Not because they are convinced that this newest coronavirus presents an immediate or inevitable public health threat. But because the remarkable success in containing the 2003 SARS epidemic demonstrated the value of a swift, and coordinated, global public health response.

 

The future of NCoV is highly uncertain right now. It could continue to threaten - or it could easily fizzle – finding itself unable to adapt well enough to humans to thrive. 

 

These are, as they say, early days.

 

But if NCoV does fade away, it might very well be due to the unsung efforts of local, regional, and global health officials and researchers (at the WHO, ECDC, CDC, CHP, HPA, etc) who are currently seeking to better understand this virus, and contain its spread.

 

The old saying is true, `When public health works, nothing happens’.

Wednesday, December 19, 2012

Ready or Not? TFAH Report 2012

image

Download Link

 

 

# 6795

 

For the tenth year in a row, the Trust for America’s Health (TFAH), has produced a comprehensive report on the the level of preparedness for all 50 states and the District of Columbia.

 

You can find, and compare progress, from my coverage of earlier editions of this report:

 

TFAH: 2011 Ready or Not Report
TFAH Ready Or Not Report: 2010
TFAH: Ready Or Not 2009


From today’s Press Release:

 

Ready or Not?

Protecting the Public from Diseases, Disasters, and Bioterrorism

December 2012

In the 10th annual Ready or Not? Protecting the Public from Diseases, Disasters, and Bioterrorism report, 35 states and Washington, D.C. scored a six or lower on 10 key indicators of public health preparedness.

The report found that while there has been significant progress toward improving public health preparedness over the past 10 years, particularly in core capabilities, there continue to be persistent gaps in the country's ability to respond to health emergencies, ranging from bioterrorist threats to serious disease outbreaks to extreme weather events.

In the report, Kansas and Montana scored lowest - three out of 10 - and Maryland, Mississippi, North Carolina, Vermont and Wisconsin scored highest - eight out of 10.

"In the past decade, there have been a series of significant health emergencies, including extreme weather events, a flu pandemic and foodborne outbreaks," said Jeffrey Levi, PhD, executive director of TFAH. "But, for some reason, as a country, we haven't learned that we need to bolster and maintain a consistent level of health emergency preparedness. Investments made after September 11th, the anthrax attacks and Hurricane Katrina led to dramatic improvements, but now budget cuts and complacency are the biggest threats we face."

(Continue . . . )

 

You can download the entire 76-page report here.  Each state is ranked based on ten preparedness criteria. A rating of 10 is the highest, although no state exceeded an 8. 

image

 

The report, which is worth reading in its entirety, contains these key findings:

 

image

 

You’ll find an interactive map, with links to each individual state’s report at :

 

http://healthyamericans.org/report/101/

Friday, July 20, 2012

The Return Of Naegleria fowleri

image

L & R: Trophozoites of N. fowleri in brain tissue, stained with H&E. Center: Ameboflagellate trophozoite of N. fowleri. Credit: DPDx

 


# 6442

 

While it is exceedingly rare, each summer we hear of one or two fatal cases of PAM (Primary Amoebic Meningoencephalitis) here in the United States caused by an infection usually acquired while swimming in warm lakes and streams.

 

Tragically, an 8-year old boy from South Carolina has become the latest victim (see Amoeba kills Sumter youthThe State).

 

Blake Driggers reportedly fell ill a week after swimming in Lake Marion and was rushed to the hospital by his family.

 

Roughly a week later he died. With no effective treatment, survival with this infection is very rare. 

 

Last year, in Sometimes It’s Zebras I wrote about this usually fatal form of meningitis caused by the Naegleria fowleri parasite.

 

N. flowleri is an amoeba, which can often be found in the silt at the bottom of warm water lakes and streams. If absorbed through the nostrils - it can make a beeline towards the brain.

 

Although usually only a danger to swimmers, last year we saw a new wrinkle when 2 people in Louisiana became infected through the introduction of tap water into their sinuses using a neti pot.

 

image

Photo Credit – Wikipedia Commons


These incidents caused the Louisiana Health Department to recommend that people `use distilled, sterile or previously boiled water to make up the irrigation solution’ (see Neti Pots & Naegleria Fowleri).

 

While it made a lot of headlines, this was not the first time that nasal irrigation has been linked to PAM. Several years ago N. fowleri contaminated tap water in Karachi, Pakistan may have caused 13 cases over 18 months.

 

According to the CDC’s FAQ on Naegleria, we average 2 to 4 infections each year in the United States with this parasite.  They list the common sources of the amoeba as:

Where is Naegleria fowleri found?

Naegleria fowleri is found around the world. In the United States, the majority of infections have been caused by Naegleria fowleri from freshwater located in southern-tier states (2). The ameba can be found in:

  • Bodies of warm freshwater, such as lakes and rivers
  • Geothermal (naturally hot) water, such as hot springs
  • Warm water discharge from industrial plants
  • Geothermal (naturally hot) drinking water sources
  • Soil
  • Swimming pools that are poorly maintained, minimally-chlorinated, and/or un-chlorinated
  • Water heaters with temperatures less than 47°C (3, 4)

Naegleria fowleri is not found in salt water, like the ocean.

 

Since millions of people swim in waters where this amoeba naturally occur (or are otherwise exposed) and only a small handful of infections result, the odds of acquiring this infection are extraordinarily low.

 

But the Florida Department of Health has some common sense safety advice on how to avoid this parasite.

 

image

Photo Credit – Florida DOH

For more information on the Naegleria parasite, you can visit the CDC’s Naegleria webpage.

 

UPDATE:

While I was writing this blog, Ronan Kelly and Alert over at FluTrackers were posting on a recent spate of deaths due to Naegleria – once again in Karachi, Pakistan.

 

The number of deaths being reported varies depending on the source, but the media is reporting between 3 and 8 fatalities over the past couple of weeks. 

 

You can follow the media reports in this thread.

Tuesday, June 12, 2012

Updating Public Health Practices (PHP)

 

image

 


# 6381

 

 

Every few months I try to highlight the Public Health Practices project (formerly Promising Practices), a freely accessible repository of public health tools and strategies, sponsored by CIDRAP at the University of Minnesota, in partnership with the Association of State and Territorial Health Officials (ASTHO).

 

 

I’ve been remiss in not mentioning them since late last year, especially since they are currently seeking feedback from visitors on how they are doing.

 

After you’ve explored their site, there is a short survey they would appreciate your answering.

 

 

Over the past year Public Health Practices has broadened its original scope to include more than just pandemic response. You’ll find tools and practices that cover a wide range of public health concerns, including chemical, radiological, and natural disasters.

 

image

 

In addition to the constantly expanding website, there is also a monthly email newsletter you can sign up for.

 

The About Us page provides an overview of the mission of the Public Health Practices website:

 

Features of Public Health Practices include:

  • More than 300 public health practices in 9 categories of emergency preparedness and disaster response from state and local health agencies, community-based organizations, and colleges and universities.
  • In-depth stories on how state and local projects were created, communications materials in more than 40 languages, and tools like job action sheets and media campaigns.
  • Expert reviewers' commentary on a practice's effectiveness, reach, sustainability, feasibility, and transferability. Please note: expert review is only available for a select number of practices.
  • A regular e-newsletter featuring our newest practices and other updates from the CIDRAP Public Health Practices staff.
  • The ability to search for practices based on geography, available languages, and key topics in preparedness and response.

 

 

If you are interested in starting a community public health, preparedness, or response program - or one for a college or university - a visit to this website could save you and your organization or agency a lot of time, money, and aggravation.

 

Some recent additions to the site include:

 

Recent Practices

Curriculum trains children to act as disaster preparedness ambassadors to their families

 

Guidance helps integrate concerns about sexual violence into the roles and procedures of disaster responders

 

Parochial Armenian schools develop and implement an earthquake preparedness program

 

Framework provides strategies for addressing resource scarcity in hospitals and clinics during a regional response

 

Toolkit paves the way for hospitals to meet children's needs during a disaster

 

Partnership with Civil Air Patrol allows winter transport of emergency medications to Michigan's Upper Peninsula

 

 

Whether you are looking for a specific solution, or simply looking for muse to inspire your organization’s emergency preparedness efforts, visiting Public Health Practicesand returning often – will likely pay tremendous dividends.

 

Highly recommended.

Friday, June 08, 2012

How The ECDC Will Spend Your Summer Vacation

 

 

# 6374

 

This summer there will be three high profile, well-attended public events in Europe; The London Olympics and Para-Olympics Games, and the UEFA EURO 2012 football championship (which is being hosted by Poland and the Ukraine).

 

Hundreds of thousands of visitors will converge on multiple venues over the summer, coming from all parts of Europe and around the world.  And as with any large gathering of people, there are serious public health concerns.

 

Over the past few months we’ve seen some hyperbolic media stories suggesting that these games could help launch the next pandemic, but past experience with other big travel events, like the Hajj, the Carnival in rio, The World Cup,  or our own Super Bowl suggests that is unlikely.

 

It is true that some disease outbreaks have been exacerbated by the gathering of large crowds. 

 

This past year a number of people were exposed to measles at the Super Bowl in Indianapolis, leading to a limited outbreak of the disease (mostly among the unvaccinated).

 

Perhaps most famously, the city of Philadelphia went ahead with plans to hold a Liberty Loan parade in September of 1918, which was attended by 200,000 people.

 

Although the flu pandemic had already begun, the city fathers were apparently heartened by the low number of cases that had been reported in Philadelphia. Other cities, like St. Louis, banned public gatherings, closed movie theatres, and even limited church gatherings.

 

What happened next is best demonstrated by the following graph, which depicts an explosion of pandemic flu cases beginning just days after the parade.

The chart above, taken from the PNAS journal article entitled Public Health Interventions and Pandemic Intensity During the 1918 Influenza Pandemic , shows the excess mortality in two American cities.

 

The tall spike represents Philadelphia, while the lower curve represents St. Louis.

 

Over the next three weeks, at least 6,081 deaths from influenza and 2,651 deaths from pneumonia were registered in Pennsylvania, most occurring in Philadelphia (CDC source).

 

So the potential is there, assuming that a novel pathogen to which there is limited immunity is introduced to the crowds.

 

The good news is, that while mass gatherings provide greater opportunities for disease outbreaks, history has shown that serious outbreaks like that which followed the 1918 Philadelphia parade are a rarity.

 

Still, there is enough concern that a good deal of planning has gone into the surveillance and prevention of disease spread at these summer events. Earlier this year in Lancet: Mass Gatherings And Health, we looked at a 6-part series on public health measures during mass gathering events.

 

 

The ECDC has published a report today outlining some of the steps they are taking to try to prevent disease outbreaks during these mass gathering events.

 

Watching the summer games

08 Jun 2012

Two large mass gathering events involving millions of EU citizens and worldwide visitors are being hosted this summer in the EU: the UEFA EURO 2012 football championship and London 2012 Olympic and Paralympic Games.

 

ECDC is enhancing its surveillance activities this summer, watching for any infectious disease health events that could present a public health threat during these sport events. As of today, a summary of relevant health events will be included in the weekly Communicable Disease Threat Report (CDTR), published on this website.

 

ECDC is working with the hosting country competent bodies of Poland, the United Kingdom and the Ukraine to provide international surveillance activities in order to support their public health actions.

 

Global mass gathering events can present challenges for public health because of their scale and the possible additional demands made of the public health services. To tackle these challenges, surveillance systems can be enhanced to target specific diseases or syndromes and to support timely response actions to reduce their impact and risk of spread.

 

Based on its founding regulation, one of the core functions of ECDC is undertaking daily 24/7 epidemic intelligence. This term encompasses activities related to early identification of potential health threats, as well as their verification, assessment and investigation, in order to recommend adequate public health control measures. Epidemic intelligence sources of information vary from health data routinely collected through standardised surveillance systems to unstructured official and unofficial reports of any origin.

 

What will ECDC be doing during these mass gathering events?

During the months of June-September 2012, ECDC is undertaking enhanced event-based surveillance as part of its routine epidemic intelligence activities. It has adapted media screening tools and its procedures to assist detecting timely infectious disease threats which may be relevant for these events, and the hosting and participating countries. The use of social media and blog fora as a mechanism of timely identification of disease threats is being explored in this context.

 

ECDC is working very closely with the hosting countries and international partners such as the World Health Organisation, including having liaison officers to facilitate daily communication with ECDC. A daily bulletin containing information on events relevant from a public health perspective will be provided to public health authorities of Member States and the event-hosting countries.

 

A summary of relevant infectious disease threats will be included in the weekly CDTR published on this website.

 

What kind of infectious diseases is ECDC looking for?

Large gatherings of people may be subject to increased public health risks, including non-communicable diseases. Based on experience from previous such mass gatherings, it is unlikely that infectious diseases will be a major problem at these two events.

 

The greatest risk for visitors to these mass gatherings is likely to be related to food and waterborne diseases, such as food poisoning due to inappropriately handled food items or inadequate hand hygiene practices. At the same time, in the context of outbreaks of measles and other vaccine preventable diseases in Europe, unvaccinated and non-immune people may be at increased risk of infection.

 

In addition to food- and water-borne diseases and vaccine preventable diseases, ECDC will be monitoring for a wide range of infectious diseases and syndromes through available data sources and networks, as it does on a daily basis, in order to detect unusual events or outbreaks.

 

The organisers of these mass gatherings have published public messages about how to stay healthy in order to best enjoy these events. Preventative measures that people can take themselves and can contribute to keeping others healthy include things such as: washing hands regularly, ensure relevant vaccinations are up to date, practice safe sex, stay out of the sun, and stay at home if you feel unwell. For those seeking travel or health advice, specific information for EURO 2012 and London 2012 can be found below.

ECDC Rapid risk assessment on measles

WHO European Region on health planning for large events

 

 

Assuming that no large outbreaks of illness or disease occurs, it will be due primarily to the advance work done by local and regional public health officials in planning for these events.

 

The old saying is true, `When public health works, nothing happens’.